The study results were published recently [48] and indicated that liraglutide did not improve clinical stability but was rather associated with a numerical but not statistically significant increase in the composite of death or HF hospitalization compared with placebo
Conversely, if you are on injections but struggling with side effects, switching to drops might provide adequate results with better tolerability
Acarbose has been found to inhibit the activation of interferon- inducible protein-10, monocyte chemoattractant protein-1, macrophage-derived chemokine, and TNF-, and to downregulate NF-B-P65 activity in human monocytic THP-1 cells
Ipamorelin is used in research as a ghrelin-receptor agonist to compare downstream signaling behavior with CJC-1295 (No DAC)
For people who want appetite support without an injection, it's a legitimate starting point
They act as a bridgenot a crutchto sustainable change